NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Serum seeks emergency use approval for Oxford's coronavirus vaccine
    India

    Serum seeks emergency use approval for Oxford's coronavirus vaccine

    Serum seeks emergency use approval for Oxford's coronavirus vaccine
    Written by Shalini Ojha
    Dec 08, 2020, 12:16 am 3 min read
    Serum seeks emergency use approval for Oxford's coronavirus vaccine

    Pune-based Serum Institute of India (SII) has sought emergency use authorization from Drugs Controller General of India (DCGI) for the coronavirus vaccine, which is developed by the University of Oxford and the British-pharma giant AstraZeneca, multiple reports said. The Adar Poonawalla-run company has become the second firm after US-based Pfizer to seek approval of this nature. Here are more details.

    "Covishield is effective," SII informed DCGI

    In the application, SII drew attention to four clinical studies of the vaccine, two of which happened in the UK and one each in Brazil and India. The vaccine, dubbed Covishield here, is effective against severe COVID-19 infections, SII is learned to have told DCGI. To note, UK and Bahrain gave the authorization to use the vaccine last week.

    "Vaccine can be used to prevent disease in targeted population"

    "Covishield is safe and well-tolerated and can be used effectively for prevention of COVID-19 in the targeted population. Thus, the benefit to risk ratio strongly supports the widespread use of Covishield," a source told PTI, citing SII's submission.

    Committed to making India "aatmanirbhar": SII

    Twelve batches of the vaccine have also been sent by SII to the Central Drugs Laboratory (CDL) in Kasauli for testing, a source informed HT. The application, reportedly signed by Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs, at SII, said the company is committed to fulfilling "Prime Minister's clarion call of vocal for local and making in India for the world."

    Fulfilled our promise: Poonawalla

    As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD. This will save countless lives, and I thank the Government of India and Sri @narendramodi ji for their invaluable support.

    — Adar Poonawalla (@adarpoonawalla) December 7, 2020

    Application received, government will begin process in few days

    Now that SII has sent an application, the government will begin the regulatory process of emergency authorization approvals in a few days, reports IE. The government will also ponder over COVAXIN, the first indigenous vaccine being developed by Bharat Biotech. "The Prime Minister has already said that a vaccine tested here will be ready in the next few weeks after regulatory approvals," sources disclosed.

    SII's trials continued even after volunteer mentioned severe side-effects

    Earlier, the government chose against stopping the trials of Covishield, even after a Chennai-based volunteer claimed the doses made him severely ill. A 40-year-old participant sought Rs. 5 core compensation from SII alleging that he suffered from side-effects, including virtual neurological breakdown and impairment of cognitive functions. In response, SII said it would seek Rs. 100 crore in damages, and rubbished his claims.

    Pfizer's application has been forwarded to committee for scrutiny

    Notably, SII's product fits well in India's picture as it can be stored between two and eight degrees Celsius. The one developed by Pfizer needs to be stored in ultra-low temperatures. Nevertheless, DCGI has forwarded its application to the Subject Expert Committee (SEC) for detailed scrutiny. The experts at SEC will submit their findings to DCGI, which will dictate the decision.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Pfizer
    Oxford
    University of Oxford
    Coronavirus

    Latest

    BWF Rankings: PV Sindhu drops out of top 10  BWF World Tour
    What is Apple Music Classical and how to use it Apple
    Box office buzz: 'Bholaa' predicted to rake in decent figures Box Office
    5 ropeways in India with the most stunning views Travel And Tourism

    Pfizer

    Pfizer acquires Seagen for $43 billion to improve cancer treatments Cancer
    Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine BioNTech
    'Cautious optimism' after initial Omicron studies; here's what we know World Health Organization
    COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Serum Institute of India

    Oxford

    Cambridge Dictionary alters 'man' and 'woman' definitions, faces criticism Social Media
    Coronavirus vaccine consignment awaits government nod for take-off from Pune Pune
    India set to start COVID-19 vaccination; panel approves Oxford vaccine University of Oxford
    India could approve coronavirus vaccine soon, key meeting today Pfizer

    University of Oxford

    COVID-19 increases risk of brain fog, dementia: Study COVID-19
    Oxford University testing COVID-19 vaccine in children Coronavirus
    Over 10 lakh inoculated, India's vaccination drive picks pace India
    Sleeves up! Coronavirus vaccination drive could begin on January 13 Union Health Ministry

    Coronavirus

    UP: CM holds meeting with Team 9 amid COVID-19 resurgence COVID-19
    India records nearly 1,600 daily COVID-19 cases—highest in 5 months COVID-19
    PM Modi to hold high-level meeting amid rising COVID-19 cases Narendra Modi
    India reports highest daily COVID-19 cases in 2023: Check tally COVID-19 India

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023